Summit Global Investments’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-14,785
Closed -$339K – 554
2024
Q2
$339K Buy
14,785
+2,683
+22% +$82.7K 0.02% 405
2024
Q1
$479K Buy
12,102
+3,892
+47% +$154K 0.04% 334
2023
Q4
$325K Sell
8,210
-242
-3% -$10.1K 0.02% 415
2023
Q3
$375K Buy
8,452
+310
+4% +$13.5K 0.03% 388
2023
Q2
$354K Buy
8,142
+1,642
+25% +$72.2K 0.02% 397
2023
Q1
$283K Sell
6,500
-1,000
-13% -$44.2K 0.02% 435
2022
Q4
$280K Buy
+7,500
New +$290K 0.02% 402

Other funds holding NRC

Summit Global Investments's NRC Position: Q3 2024 in Review

Summit Global Investments sold out of NRC Health Common Stock (NRC) in Q3 2024, closing a stake of 14,785 shares — an estimated $339K sold.

Summit Global Investments first reported a position in NRC in Q4 2022 and held it in 7 quarters. The position peaked at $479K in Q1 2024. 138 funds tracked by Wall St. Rank hold NRC as of Q3 2024.

  • Summit Global Investments reported no remaining NRC Health Common Stock position as of Q3 2024 after selling out during the quarter.
  • Summit Global Investments sold 14,785 NRC Health Common Stock shares in Q3 2024, an estimated $339K.
  • Summit Global Investments first reported a position in NRC Health Common Stock in Q4 2022 and held it in 7 quarters.
  • Summit Global Investments's NRC Health Common Stock position peaked at $479K in Q1 2024.
  • 138 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2024.

Based on Summit Global Investments's 13F filing for Q3 2024, filed 31 Oct 2024.